These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 37626031)

  • 1. New insight into protein glycosylation in the development of Alzheimer's disease.
    Zhao J; Lang M
    Cell Death Discov; 2023 Aug; 9(1):314. PubMed ID: 37626031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Glycosylation in Alzheimer's Disease.
    Haukedal H; Freude KK
    Front Neurosci; 2020; 14():625348. PubMed ID: 33519371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-glycan and Alzheimer's disease.
    Kizuka Y; Kitazume S; Taniguchi N
    Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2447-2454. PubMed ID: 28465241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reelin expression and glycosylation patterns are altered in Alzheimer's disease.
    Botella-López A; Burgaya F; Gavín R; García-Ayllón MS; Gómez-Tortosa E; Peña-Casanova J; Ureña JM; Del Río JA; Blesa R; Soriano E; Sáez-Valero J
    Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5573-8. PubMed ID: 16567613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Stage Glycosylation Biomarkers in Alzheimer's Disease.
    Regan P; McClean PL; Smyth T; Doherty M
    Medicines (Basel); 2019 Sep; 6(3):. PubMed ID: 31484367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer's disease.
    Mumtaz I; Ayaz MO; Khan MS; Manzoor U; Ganayee MA; Bhat AQ; Dar GH; Alghamdi BS; Hashem AM; Dar MJ; Ashraf GM; Maqbool T
    Front Aging Neurosci; 2022; 14():977411. PubMed ID: 36158539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer's disease.
    Taniguchi N; Takahashi M; Kizuka Y; Kitazume S; Shuvaev VV; Ookawara T; Furuta A
    Glycoconj J; 2016 Aug; 33(4):487-97. PubMed ID: 27325408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational modifications of tau protein in Alzheimer's disease.
    Gong CX; Liu F; Grundke-Iqbal I; Iqbal K
    J Neural Transm (Vienna); 2005 Jun; 112(6):813-38. PubMed ID: 15517432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of protein glycosylation in Alzheimer disease.
    Schedin-Weiss S; Winblad B; Tjernberg LO
    FEBS J; 2014 Jan; 281(1):46-62. PubMed ID: 24279329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of APP
    Akasaka-Manya K; Manya H
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33218200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach.
    Kanninen K; Goldsteins G; Auriola S; Alafuzoff I; Koistinaho J
    Neurosci Lett; 2004 Sep; 367(2):235-40. PubMed ID: 15331161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Reelin Signaling in Alzheimer's Disease.
    Yu NN; Tan MS; Yu JT; Xie AM; Tan L
    Mol Neurobiol; 2016 Oct; 53(8):5692-700. PubMed ID: 26491027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
    Boix CP; Lopez-Font I; Cuchillo-Ibañez I; Sáez-Valero J
    Alzheimers Res Ther; 2020 Aug; 12(1):96. PubMed ID: 32787955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease.
    Li H; Wang X; Yu H; Zhu J; Jin H; Wang A; Yang Z
    Curr Neuropharmacol; 2018; 16(6):758-768. PubMed ID: 29086699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
    Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
    J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.
    Sáez-Valero J; Fodero LR; Sjögren M; Andreasen N; Amici S; Gallai V; Vanderstichele H; Vanmechelen E; Parnetti L; Blennow K; Small DH
    J Neurosci Res; 2003 May; 72(4):520-6. PubMed ID: 12704813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Effects of Natural Drugs on Alzheimer's Disease.
    Ma Y; Yang MW; Li XW; Yue JW; Chen JZ; Yang MW; Huang X; Zhu LL; Hong FF; Yang SL
    Front Pharmacol; 2019; 10():1355. PubMed ID: 31866858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral Sclerosis.
    Yang J; Li H; Zhao Y
    Chembiochem; 2023 Aug; 24(16):e202300017. PubMed ID: 37440197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel model of secreted human tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity.
    Losev Y; Paul A; Frenkel-Pinter M; Abu-Hussein M; Khalaila I; Gazit E; Segal D
    Sci Rep; 2019 Feb; 9(1):2254. PubMed ID: 30783169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling the culprit in Alzheimer's disease (AD): bacterial toxic proteins - Will they be significant for the aetio-pathogenesis of AD and the transmissible spongiform encephalopathies?
    Schmitt HP
    Med Hypotheses; 2007; 69(3):596-609. PubMed ID: 17337124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.